2ϩ release from the sarcoplasmic reticulum via the ryanodine receptor (RyR2) activates cardiac myocyte contraction. An important regulator of RyR2 function is FKBP12.6, which stabilizes RyR2 in the closed state during diastole. ␤-Adrenergic stimulation has been suggested to dissociate FKBP12.6 from RyR2, leading to diastolic sarcoplasmic reticulum Ca 2ϩ leakage and ventricular tachycardia (VT). We tested the hypothesis that FKBP12.6 overexpression in cardiac myocytes can reduce susceptibility to VT in stress conditions. Methods and Results-We developed a mouse model with conditional cardiac-specific overexpression of FKBP12.6.
T he cardiac ryanodine receptor (RyR2), a tetrameric Ca 2ϩ channel located in the sarcoplasmic reticulum (SR), plays a key role in excitation-contraction coupling. During an action potential, membrane depolarization promotes transmembrane Ca 2ϩ influx through voltage-gated L-type Ca 2ϩ channels. The resulting local elevation of the free intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) leads to the release of a larger amount of Ca 2ϩ from the SR via RyR2, thereby triggering cell contraction. 1 Subsequently, cytoplasmic Ca 2ϩ is pumped back into the SR via the SR Ca 2ϩ -ATPase (SERCA2a) and extruded from the cell via the Na ϩ -Ca 2ϩ exchanger (NCX), leading to cell relaxation. RyR2 is at the center of a macromolecular complex of several proteins such as FKBP12.6 (also known as calstabin 2), calmodulin, CaM kinase II␦c (CaMKII), sorcin, and phosphatases PP1 and PP2A. 2 FKBP12.6 is a small cytosolic protein with cis-trans peptidyl-prolyl isomerase activity that binds to the RyR2 channel. 3 FKBP12.6 binding stabilizes the RyR2 in its closed state during diastole. 4 Disruption of this binding by the immunosuppressive agent FK506 increases the open proba-bility of the RyR2 channel, thereby leading to an aberrant increase in diastolic [Ca 2ϩ ] i 5 and increasing the risk of ventricular arrhythmias. 6, 7 
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It has been proposed that ␤-adrenergic stimulation during physical or emotional stress, as well as chronic activation of the sympathetic nervous system in heart failure, reduces FKBP12.6 binding to RyR2. 8 However, the role of protein kinase A-dependent RyR2 phosphorylation in FKBP12.6 dissociation is controversial. 8 -10 FKBP12.6-deficient mice (FKBP12.6 Ϫ/Ϫ ) consistently exhibit exercise-induced ventricular arrhythmias. 11 In mice with reduced FKBP12.6 levels (FKBP12.6 ϩ/Ϫ ), pretreatment with the 1,4-benzothiazepine derivative JTV519 prevents death caused by exercise-induced ventricular tachycardia, probably by enhancing FKBP12.6 binding to RyR2. 12, 13 Recently, Huang et al 14 used a constitutive model to show that cardiac FKBP12.6 overexpression protects in part against post-myocardial infarction remodeling. In vitro, FKBP12.6 overexpression has been shown to reduce diastolic SR Ca 2ϩ efflux. 5, 15 To the best of our knowledge, it has not yet been determined whether FKBP12.6 overexpression protects from arrhythmias. We therefore used the Tet-Off system to create a model of conditional FKBP12.6 overexpression. Induction of FKBP12.6 overexpression was started at weaning, and mice were examined 6 to 8 weeks later for cardiac morphology, cardiac function, level of FKBP12.6 binding to RyR2, RyR2 phosphorylation, and susceptibility to triggered arrhythmias; excitation-contraction coupling and SR Ca 2ϩ handling were examined in isolated ventricular myocytes.
Methods

Generation of Conditional FKBP12.6-Overexpressing Mice
Transgenic (TG) mice with single-copy transgene insertion were generated as described 16 using a 491-bp cDNA fragment containing the full-length coding sequence of the mouse FKBP12.6 gene (BC061121, Genebank). Double-TG (DT) mice were obtained by crossing the tetO-FKBP12.6 mice with the ␣-MHCtTA transactivator (tTA) mouse strain (kindly provided by G.I. Fishman, Mount Sinai School of Medicine, Queens, NY), 17 allowing cardiac-specific and doxycycline-regulated expression of FKBP12.6. Wild-type, ␣-MHCtTA, tetO-FKBP12.6, and DT mice were identified by Southern blot. All mice used in the present study were maintained on doxycycline until weaning (21 days). Cardiac FKBP12.6 expression increased markedly to reach a plateau within 2 to 3 weeks after doxycycline withdrawal. Two-to 3-month-old male mice were used for the experiments. Wild-type mice did not differ from mono-TG tTA mice in any of the parameters; accordingly, their data were pooled, and they are referred to as controls.
Immunoblots of Cardiac Lysates
Immunoblots were prepared from homogenates of ventricular tissue and on isolated cells collected after enzymatic dissociation 18 using anti-FKBP12 (1:1000), anti-RyR2 (C3-33, 1:1000), anti-PLB (1:5000), and anti-calsequestrin (1:2500) antibodies from Affinity Bioreagents (Golden, Colo); a custom-made anti-FKBP12.6 (1:100) antibody from Eurogentec; anti-SERCA2a antibody (N-19, SantaCruz Biotechnology Inc, Santa Cruz, Calif; 1:200); and anti-NCX antibody (R3F1, Swant, Bellinzona, Switzerland; 1:1000). RyR2-FKBP12.6 was coimmunoprecipitated as described. 19 Immunoblots of RyR2 phosphorylation were performed from heart homogenates using anti-RyR2-PS2808 (1:2000) and anti-RyR2-dePS2808 (1:2000) antibodies from Badrilla (Lees, West Yorkshire, UK) and anti-RyR2-PS2814 (1:5000) antibody generously provided by Dr A.R. Marks (Columbia University, New York, NY).
ECG Recording and Intracardiac Recording and Pacing
ECG recordings were performed as described on mice anesthetized by intraperitoneal injection of etomidate (25 mg/kg, Janssen-Cilag, Belgium). 20 After ECG recording, anesthesia was prolonged by an additional intraperitoneal injection of etomidate. The extremity of a 2F quadripolar catheter specially designed by Biosense (Johnson & Johnson) was placed in the right ventricle through the right internal jugular vein. Standard pacing protocols were used to determine the ventricular effective refractory periods and to induce ventricular arrhythmias. The inducibility of ventricular arrhythmias was assessed at baseline and after infusion of isoproterenol 0.2 mg/kg IP by using the programmed electric stimulation (PES) method with 1 to 3 extrastimuli and burst pacing. Burst pacing consisted of trains of 20 to 100 paced beats at a cycle length of 50 ms, with at least a 4-second interval between 2 successive trains for an overall duration of 2 minutes. PES was started 2 to 3 minutes after injection of isoproterenol and lasted 15 to 17 minutes. Ventricular tachycardia (VT) was defined as the occurrence after the last paced beat of at least 4 consecutive QRS complex beats with a morphology different from that seen in normal sinus rhythm. 21 VT of Ͼ10 cycles was defined as sustained VT.
Ca
2؉ Imaging and Cellular Electrophysiology
Single ventricular myocytes were prepared by enzymatic dissociation as described. 18 Myocytes were loaded with the cell-permeant Ca 2ϩ fluorescent dye fluo-3 AM. Confocal images (Meta Zeiss LSM 510) were acquired in the line-scan mode at 1.5 ms per line. L-type Ca 2ϩ current (I Ca,L ) was measured with the whole-cell patch-clamp technique (Axopatch-1D amplifier, Axon Instruments) with 1.0-to 1.8-M⍀-resistance micropipettes. Calcium imaging and electrophysiology experiments were performed at room temperature (21°C to 24°C).
Data Analysis
A detailed Methods section can be found in the online Data Supplement.
Data are expressed as meanϮSEM. Parametric tests were used to compare normally distributed variables (1-factor ANOVA to compare DT, tTA, and WT mice; unpaired t test for comparisons between DT and controls; and paired t test to assess the effect of isoproterenol in confocal microscopy experiments). Fisher's exact test was used to compare the incidence of arrhythmias in DT and control mice. Nonparametric 2-factor ANOVA and a Mann-Whitney test were used to compare RyR2 phosphorylation status between DT and controls in basal conditions and on isoproterenol stimulation. Nominal values of PϽ0.05 were considered to denote statistically significant differences.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results
Baseline Characterization of TG Mice
No deaths occurred during transgene induction. Six to 8 weeks after doxycycline withdrawal, control and DT mice did not differ in terms of morphological or functional parameters (the Table) . Myocardial sections stained by Masson's trichrome, Sirius red, and hematoxylin and eosin did not show any histological alteration in DT mice (not shown). Reverse-transcription polymerase chain reaction specific for TG FKBP12.6 mRNA showed strong TG expression in the ventricular myocardium, whereas TG expression in other tissues was nearly (brain, lung) or totally (kidney, liver, skeletal muscle) undetectable at 30 polymerase chain reaction cycles using 100 ng total cDNA per organ ( Figure 1A ). Western blot analysis using the anti-FKBP12 antibody yielded a strong FKBP12.6 signal in ventricular homogenates from DT mice, whereas the endogenous FKBP12.6 was not detected in control mice ( Figure 1B ). Our anti-FKBP12.6 -specific antibody detected the endogenous FKBP12.6 in control mice and showed a marked FKBP12.6 overexpression in DT mice ( Figure 1C ). These data demonstrated strong and cardiac-specific FKBP12.6 overexpression in DT mice. The expression levels of FKBP12, RyR2, SERCA2a, phospholamban, and calsequestrin were not significantly altered ( Figure 1B and 1C) . Thus, FKBP12.6 overexpression for 6 to 8 weeks did not alter cardiac morphofunctional parameters or the expression level of the main Ca 2ϩ -handling SR proteins.
ECG, Intracardiac Recording, and Pacing
Surface ECG parameters were examined in 14 DT and 28 control mice before catheter introduction and ventricular pacing ( Figure 2A ). No significant differences were observed in RR (DT, 142Ϯ6 ms; controls, 136Ϯ5 ms), PQ (DT, 37Ϯ1 ms; controls, 36Ϯ1 ms), QRS (DT, 14Ϯ0 ms; controls, 14Ϯ0 ms), or QTc (DT, 56Ϯ2 ms; controls, 54Ϯ1 ms) intervals. Intracardiac ECG recordings in DT and control mice also were similar ( Figure 2B ). In baseline conditions, FKBP12.6 overexpression had no effect on the ventricular effective refractory period measured at a basic cycle length of 100 ms (DT, 36Ϯ2 ms; controls, 39Ϯ2 ms; PϭNS) or under sinus rhythm (DT, 32Ϯ2 ms; controls 35Ϯ2 ms; PϭNS). Paced extrasystoles induced VT in 5 of 28 controls (18%) and in 5 of 14 DTs (36%; PϭNS; data not shown). After intraperitoneal injection of isoproterenol, the spontaneous heart rate was too fast to pace at a cycle length of 100 ms. Ventricular effective refractory period under sinus rhythm was reduced to 27Ϯ1 ms in DT (PϽ0.01 versus baseline) and 28Ϯ1 ms in controls (PϽ0.001 versus baseline; PϭNS versus DT). ECG parameters also were similar in the 2 groups (data not shown). VT was induced by PES in 14 of 28 controls (50%) and 7 of 14 DTs (50%; data not shown).
In baseline conditions, burst pacing at a cycle length of 50 ms induced VT in 5 of 28 (18%) control mice (nonsustained VT in 2, sustained VT in 3) but in none of the DT mice (PϭNS). After pretreatment with isoproterenol, the same burst pacing protocol induced VT in 12 of 27 controls (44%) but in only 1 of 14 DT (7%; Pϭ0.03; Figure 2C and 2D). Of the 12 control mice with VT, 9 had sustained VT, sometimes lasting Ͼ5 seconds. The DT mouse with VT had only a short salvo of 6 cycles. Thus, after pretreatment with isoproterenol, FKBP12.6 overexpression prevented VT induced by burst pacing.
Ca
2؉ Imaging and Cellular Electrophysiology
In baseline conditions, Ca 2ϩ spark frequency was decreased by 50% in DT myocytes compared with controls (PϽ0.01; Figure 3A ). This was associated with a slight but significant increase in the averaged peak amplitude (F/F 0 ; PϽ0.01), full width at half-maximum amplitude (PϽ0.05), and full duration at half-maximum peak (PϽ0.05), indicating increased spark size ( Figure 3B ). On isoproterenol application, Ca 2ϩ spark frequency increased by 41.2Ϯ16.8% (PϽ0.05) in control cells and by 26.0Ϯ16.0% in DT myocytes (PϽ0.05, PϭNS versus controls; Figure 3C ). In DT myocytes, SR Ca 2ϩ load was unchanged compared with controls ( Figure 3D) . However, the Ca 2ϩ signal decay was prolonged, reflecting decreased NCX activity in DT myocytes (PϽ0.05).
In baseline conditions, at a stimulation frequency of 1 Hz, Ca 2ϩ transient peak amplitude was decreased by 30% in DT cells compared with controls (PϽ0.001; Figure 4A) Figure 4B ), with no change in cell fractional shortening (data not shown).
Whole-cell patch-clamp recordings showed a reduction in I Ca,L in myocytes isolated from DT mice compared with controls ( Figure 4C 
RyR2-FKBP12.6 Coimmunoprecipitation and RyR2 Phosphorylation
Coimmunoprecipitation experiments showed that the increased expression of FKBP12.6 in DT hearts resulted in markedly increased FKBP12.6 binding to RyR2 in baseline conditions that persisted on isoproterenol stimulation in both control and DT mice ( Figure 5A ). Immunoblot analysis of phosphorylated and dephosphorylated forms of RyR2 at S2808 showed no difference between DT and controls in basal conditions and on isoproterenol stimulation ( Figure 5B and 5C). In the latter condition, most S2808 sites appeared to be phosphorylated. Unexpectedly, in basal conditions, S2814 phosphorylation was found to be increased Ͼ2-fold in DT compared with control mice (PϽ0.01; (Figure 5B and 5D ). Isoproterenol stimulation increased S2814 phosphorylation almost 5-fold in control (PϽ0.01) compared with only 2-fold in DT (PϭNS) mice to reach similar levels. 
Discussion
In our conditional mouse model, cardiac FKBP12.6 overexpression increased FKBP12.6 binding to RyR2 and prevented ventricular tachycardia induced by burst pacing after pretreatment with isoproterenol. Data obtained with isolated ventricular myocytes suggest that this protection is, at least in part, due to decreased diastolic SR Ca 2ϩ release.
FKBP12.6 Overexpression Prevents Catecholamine-Promoted Ventricular Arrhythmias
PES is widely used to test the propensity of patients and experimental animals to develop ventricular arrhythmias. The electric vulnerability of mouse hearts is low and strongly dependent on strain, sex, and age. The C57Bl/6 genetic background is one of the least susceptible to develop VT after PES or burst pacing. 22 Indeed, the incidence of VT after PES or burst pacing in baseline conditions was very low in our control animals, making it impossible to detect a potential antiarrhythmic effect of FKBP12.6 overexpression.
Interestingly, in stress conditions, FKBP12.6 overexpression significantly reduced the incidence of arrhythmias induced by burst pacing but not by extrastimuli. PESinduced VTs are known to reflect reentrant mechanisms secondary to altered conduction and/or refractory periods. Because neither ventricular conduction nor refractory periods were affected by FKBP12.6 overexpression, the absence of protection against reentries in DT mice is not surprising.
The mechanism underlying arrhythmias triggered by burst pacing during ␤-adrenergic stimulation is most likely linked to delayed afterdepolarizations, as shown in mouse isolated ventricular myocytes in which delayed afterdepolarizations have been triggered in experimental conditions close to those used here. 23, 24 Indeed, the occurrence of delayed afterdepolarizations is favored by abrupt increases in heart rate and by catecholamines, 25 conditions that lead to intracellular Ca 2ϩ overload-and store overload-induced spontaneous Ca 2ϩ release via RyR2. This activates the NCX, thus generating the transient inward current (I ti ) at the origin of delayed afterdepolarizations. Alternatively, spontaneous SR Ca 2ϩ release may result from changes in RyR2 intrinsic activity as seen, for instance, with RyR2 mutations responsible for catecholaminergic polymorphic ventricular tachycardia 23 or with RyR2 phosphorylation. 19, 26 Our results suggest that the protective effect of FKBP12.6 overexpression against ventricular tachycardia induced by burst pacing after pretreatment with isoproterenol is due to decreased diastolic SR Ca 2ϩ release (see below), although a decrease in I ti likely also plays a role.
FKBP12.6 Overexpression Reduces
RyR2-Mediated Diastolic Ca 2؉ Leakage FKBP12.6 overexpression in vitro 27 or enhanced FKBP12.6 binding to RyR2 by JTV519 13 reduces SR Ca 2ϩ release events in resting cardiac myocytes, which has been proposed to occur by stabilizing RyR2 in its closed state during diastole. 4 The marked reduction in Ca 2ϩ spark frequency, which we report here in myocytes isolated from DT mice, is consistent with this hypothesis. Our results indeed show that FKBP12.6 overexpression is associated with a decreased occurrence of spontaneous openings of RYR2. Importantly, isoproterenol increased Ca 2ϩ spark frequency in a similar proportion in control and DT myocytes, thus maintaining a reduced Ca leak in DT myocytes compared with controls, consistent with the decreased incidence of ventricular arrhythmias after burst pacing in DT mice pretreated with isoproterenol.
The mechanisms by which FKBP12.6 overexpression decreased spark frequency in basal and in stress conditions in DT mice are probably complex and multiple. Our results suggest that this is due, at least in part, to the major increase in FKBP12.6 binding to RyR2. The marked apparent difference in FKBP12.6 binding to RyR2 in our coimmunoprecipitation experiments raises questions about the precise baseline stoichiometry of FKBP12.6 to RyR2. If 1 RyR2 tetramer cannot bind Ͼ4 FKBP12.6 molecules, our results suggest that the baseline binding ratio in mice is much lower that the value of 3.6 reported for the dog heart. 28, 29 Alternatively, it cannot be excluded that the maximal binding capacity exceeds 4 FKBP12.6 molecules per RyR2. Most importantly, such an increased binding persisted with isoproterenol exposure. If this holds true in isolated myocytes and in vivo, it may explain both the decreased diastolic SR Ca 2ϩ leakage and the decreased incidence of ventricular tachycardia induced by burst pacing in stress conditions.
In contrast to our study, in cultured rabbit 15, 27 and rat 5 cardiac myocytes with adenoviral FKBP12.6 overexpression, decreased Ca 2ϩ spark frequency was associated with both a decrease in Ca 2ϩ spark size and an increase in SR Ca 2ϩ load. Differences in animal species, experimental conditions, and adaptive mechanisms linked to interdependence between SR Ca 2ϩ content and transsarcolemmal Ca 2ϩ fluxes may explain this discrepancy. In cultured ventricular myocytes with adenoviral FKBP12.6 overexpression, Ca 2ϩ spark characteristics are significantly different from those observed in freshly dissociated myocytes, 15 possibly because of alterations in cell architecture (eg, loss of t tubules) and in the phosphorylation status and expression level of Ca 2ϩ -handling proteins. Moreover, differences also may be due to the duration of FKBP12.6 overexpression (short term in the transfection experiments versus long term in DT mice).
RyR2 Phosphorylation in Basal Condition and During Stress
There is a consensus that RyR2 can be protein kinase A and CaMK phosphorylated 11,30 -32 but not on whether RyR2 phosphorylation dissociates FKBP12.6 from its binding sites. 8 -10 ␤-Adrenergic stimulation increased S2808 phosphorylation to a similar extent in DT and control mice ( Figure 5C ). Similarly, RyR2 phosphorylation at S2814 increased to comparable levels in control and DT mice, consistent with the dual effect of ␤-adrenergic stimulation on protein kinase A (S2808) and CaMKII (S2808 and S2814) phosphorylation sites. 33, 34 Most importantly, our coimmunoprecipitation experiments indicated that these phosphorylations, submaximal in the case of S2808, were not accompanied by a significant dissociation of FKBP12.6 from RyR2, in agreement with previous reports. 10, 19, 35 Altogether, our results suggest that decreased SR Ca 2ϩ leakage on isoproterenol stimulation in DT mice resulted from increased FKBP12.6 binding to RyR2 despite increased RyR2 phosphorylation.
Intriguingly, in contrast to similar S2814 phosphorylation levels in DT and control mice in stress conditions, the baseline phosphorylation level at S2814 in the former was more than twice that in the latter. In view of several reports indicating an increase in Ca 2ϩ spark frequency and SR Ca 2ϩ leakage in the presence of increased CaMKII activity and/or CaMKII-mediated S2814 RyR2 phosphorylation, 19, 26, 36 it is possible that the increased baseline S2814 phosphorylation represents a long-term adaptive mechanism aimed at maintaining normal SR Ca 2ϩ load by preventing excessive decrease in SR Ca 2ϩ efflux. However, this hypothesis should be taken cautiously because the effects of S2814 phosphorylation on RyR2 function remain controversial. 37, 38 
FKBP12.6 Overexpression Effects on Transsarcolemmal Ca 2؉ Movements
The reasons for the observed decrease in I Ca,L density are unclear and require further study. The decrease could be due to FKBP12.6-induced alterations in the L-type Ca 2ϩ channelRyR2 interaction. 2 
Conclusions
Our study shows that cardiac FKBP12.6 overexpression prevents triggered ventricular arrhythmias in stress conditions without altering baseline ECG parameters or myocardial performance. The antiarrhythmic effect is probably linked to a reduced diastolic SR Ca 2ϩ leak, itself a result of increased FKBP12.6 binding to RyR2, even when the latter is heavily phosphorylated. Our results also underline the importance of in vivo studies for investigating the impact of manipulating SR Ca 2ϩ handling and support the hypothesis that FKBP12.6 binding to RyR2 is an important potential target for the development of new drugs aimed at preventing ventricular arrhythmias.
